[
    [
        {
            "time": "2023-10-18",
            "original_text": "Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "dips",
                    "broader markets"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "Biogen Slashes Alzheimer's Treatment Price Amid Launch 'Gone Awry'",
            "features": {
                "keywords": [
                    "Biogen",
                    "Alzheimer's",
                    "slashes",
                    "price",
                    "launch"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Biogen Slashes Alzheimer's Treatment Price Amid Launch 'Gone Awry'",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "Market check: Stocks open lower, yield curve steepens, oil under pressure",
            "features": {
                "keywords": [
                    "stocks",
                    "open lower",
                    "yield curve",
                    "steepens",
                    "oil",
                    "pressure"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance",
                    "energy"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Market check: Stocks open lower, yield curve steepens, oil under pressure",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "Novo Nordisk Tumbles as Contractor Issues Hit U.S. Obesity Drug Supply",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "tumbles",
                    "contractor issues",
                    "obesity drug",
                    "supply"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Novo Nordisk Tumbles as Contractor Issues Hit U.S. Obesity Drug Supply",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]